Single-Port Robotic Applications in Urology

Nguyen, Tuan Thanh; Basilius, Jacob; Ali, Sohrab N.; Dobbs, Ryan W.; Lee, David I.

doi:10.1089/end.2022.0600

Cited by 9 publications

(2 citation statements)

References 58 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…SP surgery has the potential benefits of reduced incisions, less pain, and faster recovery compared to MP surgery [ 22 ]. Criticisms of SP surgery include limited instrumentation and ability to retract, yet the single trocar system and double-articulating instruments facilitate maneuverability into a number of surgical approaches to RARP [ 23 , 24 ].…”

Section: Discussionmentioning

confidence: 99%

Minimally invasive cytoreductive radical prostatectomy, exploring the safety and feasibility of a single-port or multi-port robotic platform

Lama,

Thomas,

Vernez

et al. 2024

BMC Urol

View full text Add to dashboard Cite

Background Consolidative resection or cytoreductive radical prostatectomy (CRP) may benefit men with non-organ confined prostate cancer. We report the safety, feasibility, and outcomes of robot-assisted laparoscopic CRP using a single-port (SP) or multi-port (MP) platform. Methods We reviewed consecutive men with clinical node positive or metastatic castrate-sensitive prostate cancer who underwent IRB-approved CRP and extended pelvic lymph node dissection using the da Vinci SP or MP Surgical Systems (Intuitive Surgical, Sunnyvale, CA) from 2015–2022. Perioperative data and Clavien-Dindo 90-day complications were recorded. Results Twenty-four men with a median age of 61 (IQR 56—69) years and prostate-specific antigen of 32.1 (IQR 21.9—62.3) ng/mL were included. Clinical N1, M1, or N1 + M1 disease were detected in 8 (33%), 9 (38%), 7 (29%) patients, respectively. There was no difference in positive margins, 41% vs. 29% (P = 0.67), lymph node yield, 21 (IQR 14–28) vs. 20 (IQR 13.5–21) nodes (P = 0.31), or estimated blood loss, 150 mL (IQR 100–200) vs. 50 mL (IQR 50–125) (P = 0.06), between the MP and SP cohorts, respectively. Hospital length of stay was significantly shorter for the SP group, same-day discharge (IQR 0–0), compared to MP, 1-day (IQR 1–1), P < 0.001. One grade III bowel obstruction and lymphocele occurred in the MP cohort. No major complications occurred in the SP cohort. Conclusion Robot-assisted laparoscopic CRP is safe and feasible for select men with advanced castrate-sensitive prostate cancer.

show abstract

Section: Discussionmentioning

confidence: 99%

Minimally invasive cytoreductive radical prostatectomy, exploring the safety and feasibility of a single-port or multi-port robotic platform

Lama,

Thomas,

Vernez

et al. 2024

BMC Urol

View full text Add to dashboard Cite

show abstract

“…Currently approved for clinical use in the USA, South Korea, and Japan, the SP platform is expected to become available on the European market very soon. Since its initial clinical use [2] , a growing body of evidence has shown promising outcomes with this approach [3] , leading to increasing popularity and widespread adoption.…”

mentioning

confidence: 99%